PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
18-Nov-2024 Nine in Ten Integrated Health Systems' Outpatient Services Losing Revenue Due to Flawed RCM Systems: Deficiencies Erode Ancillaries' Financial Performance, Reports Black Book AccessWire
18-Nov-2024 CapeStart Debuts MadeAi™, its GenAI-enabled Platform for Life Sciences that Transforms Literature Review and other Applications CapeStart, Inc.
18-Nov-2024 Leadership Evolution Announced by EW Healthcare Partners AccessWire
18-Nov-2024 Webinar to Address Menopause in the Workplace AccessWire
18-Nov-2024 EW Healthcare Partners Announces Leadership Evolution AccessWire
18-Nov-2024 ZPB Associates appoints Dr Arvind Madan and Dr Jenny Shand to senior advisory team ZPB Associates
18-Nov-2024 Hypha Laboratories Announces Completion of Phase 1 of Its State-of-the-Art Facility and Arrival of V5 Working MicroPearls(TM) Prototypes AccessWire
18-Nov-2024 Glow Sauna Studios Beems Westward with Multi-Unit Expansion into Kansas City AccessWire
18-Nov-2024 CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024) AccessWire
18-Nov-2024 Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event AccessWire
18-Nov-2024 Epsom Salt Council Sponsors the Arthritis Foundation's North Carolina Jingle Bell Runs to Benefit Critical Research Initiatives AccessWire
18-Nov-2024 PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS AccessWire
18-Nov-2024 Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets AccessWire
18-Nov-2024 Tharimmune Presents Positive Clinical Data at AASLD the Liver Meeting(R) to Support TH104 for Chronic Pruritus in Chronic Liver Disease AccessWire
18-Nov-2024 Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis AccessWire
18-Nov-2024 NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders AccessWire
18-Nov-2024 Iqirvo® (elafibranor) data show efficacy and tolerability for up to 3 years in patients with PBC with improvements in fatigue and pruritus Ipsen
18-Nov-2024 Interactive Strength Inc. (Nasdaq:TRNR) Expands CLMBR’s Presence with Military and College Accounts by Exhibiting at the Athletic Business Show on November 19-22 AccessWire
18-Nov-2024 Quell Therapeutics Achieves Milestone for Type 1 Diabetes CAR-Treg Cell Therapy Program Quell Therapeutics
18-Nov-2024 Cure51 launches NHS-approved study with Cambridge University Hospitals and seven other leading UK oncology institutions to unlock cancer survival secrets Cure51